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Effects of Physical Exercise on Myocardial Telomere-
Regulating Proteins, Survival Pathways, and Apoptosis
Christian Werner, MD,* Milad Hanhoun, MD,* Thomas Widmann, MD,† Andrey Kazakov, MD,*
Alexander Semenov, MD,* Janine Pöss, MD,* Johann Bauersachs, MD,‡ Thomas Thum, MD,‡
Michael Pfreundschuh, MD,† Patrick Müller, MD,* Judith Haendeler, MD,§ Michael Böhm, MD,*
Ulrich Laufs, MD*
Homburg/Saar, Würzburg, and Düsseldorf, Germany
Objectives The purpose of this study was to study the underlying molecular mechanisms of the protective cardiac effects of
physical exercise.
Background Telomere-regulating proteins affect cellular senescence, survival, and regeneration.
Methods C57/Bl6 wild-type, endothelial nitric oxide synthase (eNOS)–deficient and telomerase reverse transcriptase
(TERT)–deficient mice were randomized to voluntary running or no running wheel conditions (n  8 to 12 per
group).
Results Short-term running (21 days) up-regulated cardiac telomerase activity to 2-fold of sedentary controls, in-
creased protein expression of TERT and telomere repeat binding factor (TRF) 2, and reduced expression of the
proapoptotic mediators cell-cycle–checkpoint kinase 2 (Chk2), p53, and p16. Myocardial and leukocyte telomere
length did not differ between 3-week- and 6-month-old sedentary or running mice, but telomerase activity, TRF2
and TERT expression were persistently increased after 6 months and the expression of Chk2, p53, and p16 re-
mained down-regulated. The exercise-induced changes were absent in both TERT/ and eNOS/ mice. Run-
ning increased cardiac expression of insulin-like growth factor (IGF)-1. Treatment with IGF-1 up-regulated myo-
cardial telomerase activity 14-fold and increased the expression of phosphorylated Akt protein kinase and
phosphorylated eNOS. To test the physiologic relevance of these exercise-mediated prosurvival pathways, apoptotic
cardiomyopathy was induced by treatment with doxorubicin. Up-regulation of telomere-stabilizing proteins by
physical exercise in mice reduced doxorubicin-induced p53 expression and potently prevented cardiomyocyte
apoptosis in wild-type, but not in TERT/ mice.
Conclusions Long- and short-term voluntary physical exercise up-regulates cardiac telomere-stabilizing proteins and thereby
induces antisenescent and protective effects, for example, to prevent doxorubicin-induced cardiomyopathy.
These beneficial cardiac effects are mediated by TERT, eNOS, and IGF-1. (J Am Coll Cardiol 2008;52:470–82)
© 2008 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.04.034h
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regular physical activity is associated with a decrease of
ardiovascular events (1,2). Physical training improves ex-
rcise capacity, endothelial function, and collateralization in
atients with coronary artery disease and chronic heart
ailure (3–5). Physical activity is associated with improved
lood pressure, insulin sensitivity, mood, body weight, and
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Klinik für Innere Medizin I, Hämatologie, Onkologie und Rheumatologie Univer-
itätsklinikum des Saarlandes, Homburg, Germany; ‡Medizinische Klinik I, Kardi-
logie, Universitätsklinikum Würzburg, Germany; and the §Institut für Umwelt-
edizinische Forschung at the Universität Düsseldorf gGmbH, Düsseldorf,
ermany. Supported by grants from the Deutsche Forschungsgemeinschaft (KFO
96) and the Universität des Saarlandes (HOMFOR).p
Manuscript received February 7, 2008; revised manuscript received March 21,
008, accepted April 14, 2008.emostatic and inflammatory variables (6). However, de-
pite the wealth of evidence derived from epidemiological
nd interventional trials, there is limited understanding of
he underlying molecular mechanisms, especially in the
eart (7).
The prevalence, incidence, and morbidity of cardiac
iseases increase with the aging human population. On the
ellular level, senescence, chromosome stability, and cell
iability are regulated by the telomeres and their associated
roteins, deoxyribonucleic acid-protein complexes located at
oth ends of eukaryotic chromosomes (8). Shortening of the
elomeres has been shown to be associated with increased
ortality rate from heart disease (9). In men and in mice, a
ibonuclear complex, called telomerase, is the central com-
onent of the telomere complex. The activity of telomerase
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August 5, 2008:470–82 Exercise Regulates Cardiac Telomere Biologyecreases in aging mouse myocytes (10). The best-
haracterized function of the telomeric complex is to protect
he chromosome ends from degradation. The enzyme te-
omerase contains a catalytic subunit, the telomerase reverse
ranscriptase (TERT). In isolated cells, TERT gene transfer
educes replicative senescence and extends the life span of
umerous cell types, including cardiac myocytes (11). Im-
ortant proteins that form the telomeric complex include
he telomere repeat binding factors (TRFs) 1 and 2, which
an directly bind to the TTAGGG repeats of telomeres.
he TRF2 protein is crucial for maintaining a normal
hromosomal end structure because it collaborates in the
rocesses leading to T-loops (12). In addition, TRF2
nteracts with other factors, serving as binding platforms for
number of additional telomere-associated proteins. The
unction of these protein complexes is not completely
nown but includes signaling to deoxyribonucleic acid
amage checkpoint controls (13,14). In addition to the
rotection of chromosome ends, the components of the
elomeric complex enhance cell survival. Suppression of
elomerase enzyme activity promotes apoptosis, whereas
verexpression of TERT prevents programmed death by
nterfering with a pre-mitochondrial step in the cell death
ascade (11,15). Gene products implicated in growth arrest
nd apoptosis, such as p53, p16, and cell-cycle–checkpoint
inase 2 (Chk2), are potential downstream effectors of the
elomeric complex and increase with age in cardiac myocytes
10,13,14,16–19).
Cardiomyocyte apoptosis has been shown to contribute
ignificantly to the pathogenesis of heart failure. In end-
tage human heart failure, myocyte apoptosis increases (20).
imilarly, acute toxic cardiomyopathy, such as that induced
y doxorubicin (a frequently used anticancer drug), is
haracterized by cellular senescence and apoptosis (21).
owever, our understanding of potential strategies to pre-
ent cardiomyocyte senescence and apoptosis is limited (20).
ere we identify and characterize voluntary exercise as a
otent measure to increase telomere-stabilizing proteins in
he myocardium and to prevent doxorubicin-induced car-
iac myocyte apoptosis.
ethods
nimals and exercising. Animal experiments were ap-
roved by the animal ethics committee of the Universität
es Saarlandes, conformed with U.S. National Institutes of
ealth’s Guide for the Use and Care of Laboratory Animals
NIH Pub. No. 85-23, revised 1996), and were conducted
n accordance to institutional guidelines. Eight-week-old
ale C57/Bl6 (Charles River Laboratories, Wilmington,
assachusetts), endothelial nitric oxide synthase (eNOS)/
B6.129/P2-Nos3, Charles River) mice, TERT/
B6.129S-Terttm1Yjc/J, mutant generation 2, Jackson Lab-
ratory, Bar Harbor, Maine) mice, and strain-matched
ontrols to the mutants were kept under usual care at 1 to 6
ice per cage. Each exercising mouse was kept in an Dndividual cage supplied with a
unning wheel (12.8-cm diame-
er) equipped with a tachometer
BC 500, Sigma Sport Europe,
eustadt, Germany) recording
he daily running distance. Mice
an voluntarily. The mean running
istance was 5,100  800 m/24
and did not differ in mice after
oxorubicin treatment as well as
n eNOS/ and TERT/
ice. Transthoracic echocardi-
graphy was performed using a
E Systems Vivid 5 scanner
GE Healthcare, Munich, Ger-
any), 13-MHz broadband
ransducer; fractional shortening,
nd-diastolic thickness of inter-
entricular septum and the left
osterior wall, as well as the left
entricular end-diastolic diame-
er was taken. Indicated mice
ere treated with doxorubicin
2.5 mg/kg (Medac, Wedel,
ermany), administered intra-
eritoneally (i.p.) for 24 h; with
rowth hormone (GH) (Sigma-
ldrich, Munich, Germany), 2.5
g GH/g/day solved in 150 l
hosphate-buffered saline (PBS)
nce per day i.p. for 7 days; with
ouse insulin-like growth factor
IGF)-1 (Sigma-Aldrich), 1.5
g mouse IGF-1/g body weight solved in 150 l PBS for 3
imes per day i.p. for 2 days; or with 150 l PBS as control
s described (22).
elomere length analysis by flow-fluorescence in-situ
ybridization (FISH) assays. Telomere length was deter-
ined by the FISH method (23). In brief, 600,000 pe-
ipheral blood leukocytes were washed once (5% dextrose,
.1% bovine serum albumin [BSA], 10 mmol/l 4-(2-
ydroxyethyl)-1-piperazineethanesulfonic acid) and resus-
ended in hybridization buffer (75% deionized formamide,
0 mmol/l tris(hydroxymethyl)aminomethane [Tris] [pH 7.1],
0 mmol/l NaCl, 1% BSA) for 10 min. After denaturing
ells, 90 min incubation with either no probe (unstained
ontrol) or 0.18 g fluorescein isothiocyanate (FITC)–
abeled, telomere-specific (C3TA2)3 deoxyribonucleic acid
robe (Applied Biosystems, Langen, Germany) was per-
ormed. After 3 rounds of washing (75% deionized form-
mide, 0.1% BSA, 10 mmol/l Tris, 0.1% Tween 20), cells
ere resuspended in PBS, 0.1% BSA, RNAse A at 10
g/ml and 0.1 g/ml LDS 751 (Exciton, Munich, Germany)
or deoxyribonucleic acid (DNA) counterstain. Flow cyto-
etric analysis was carried out on a FACSCanto (Becton
Abbreviations
and Acronyms
BSA  bovine serum
albumin
Chk2  cell-cycle–
checkpoint kinase 2
eNOS  endothelial nitric
oxide synthase
FISH  fluorescence in-situ
hybridization
GAPDH  glyceraldehyde-3-
phosphate dehydrogenase
GH  growth hormone
HEK  human embryonic
kidney
Ig  immunoglobulin
IGF  insulin-like growth
factor
i.p.  intraperitoneally
mRNA  messenger
ribonucleic acid
PBS  phosphate buffered
saline
TERT  telomerase reverse
transcriptase
TFU  telomeric
fluorescence units
TRF  telomere repeat
binding factor
Tris  tris(hydroxymethyl)
aminomethane
WT  wild-typeickinson, Heidelberg, Germany). Telomere length was
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Exercise Regulates Cardiac Telomere Biology August 5, 2008:470–82xpressed as mean fluorescent signal intensity. To control
or interday variation, FITC-labeled beads (Quantum 24,
altag, Hamburg, Germany) with defined amounts of
uorescence (molecules of equivalent soluble fluorochrome)
ere run in parallel each day. Telomere length was con-
erted into base pairs according to a previously established
tandard curve (23).
yocardial telomere length analysis by FISH. Telomere
ength is directly related to its integrated fluorescence
ntensity when marked with a specific telomere peptide
ucleic acid probe using quantitative FISH as described
24). We fixed 5-m cryosections of the hearts in 4%
araformaldehyde for 30 min at room temperature followed
y treatment with 0.1% Pepsine solution (Sigma-Aldrich)
or 10 min at 37°C. After washing and dehydration, 25 l
f the hybridization mix (70% formamide, 0.13 g Cy3-
onjugated telomere-specific peptide nucleic acid probe
C2TA3)3 (Applied Biosystems), blocking reagent (Roche,
annheim, Germany), MgCl2 buffer, and 1 mmol/l Tris
pH 7.2) was added to the sections. Denaturation was
arried out at 80°C for 3 min and preceded incubation for
h in a humid chamber and washing with wash buffer (70%
ormamide, 10 mmol/l Tris [pH 7.2], 0.1% BSA), Tris-
uffered saline (1% Tween) and PBS for a total of 1 h.
uclei were then counterstained with 4,=6-Diamidino-2-
henylindoldihydrochloride (DAPI). All sections were an-
lyzed using a Nikon E600 epifluorescence microscope
Nikon, Düsseldorf, Germany) and 1,000 magnification
y a blinded investigator. At least 3 representative high
ower fields of the Cy3 and DAPI channel from each slide
ere recorded with Lucia G software, version 4.81 (Labo-
atory Imaging for Nikon, Prague, Czech Republic) with
dentical exposure time. Telomere fluorescence intensity was
alculated with TFL-Telo freeware version 2.2.07.0418—
002 (25,26).
elomerase activity. Telomerase activity was quantified us-
ng a telomerase repeat amplification protocol (23,27,28).
rotein extracts (1 g) of mouse left ventricle, 0.1g of primer
S (5=-ATCGCTTCTCGGCCTTTT-3=) (template), 0.05
g primer ACX (5=-GCGCGG [CTTACC]3CTAACC-3=)
n 20 l LightCycler FastStart SYBR Green PCR Master
ix (Roche) containing 1.5 mmol/l MgCl2 were incubated
t 30°C for 30 min to allow template elongation by
elomerase activity. After immediate transfer to the LightCycler
nstrument (Roche), telomerase activity was terminated and
ot start DNA polymerase activated by incubation at 95°C
or 10 min. Forty cycles of amplification were carried out
ith 20 s at 95°C, 30 s at 60°C, and 50 s at 72°C.
elomerase activity was displayed as relative telomerase
ctivity to 1,000 human embryonic kidney (HEK 293) cells
Gibco, Karlsruhe, Germany). A standard titration curve of
EK 293 cells was established from 0 to 1,000 cells to
nsure linearity of the assay (R2 0.99). A positive result of
he telomerase assay was considered if the quantity of
elomerase activity was 3 times above the standard deviation
f the mean negative control’s background level (heat- 5nactivated lysate from 1,000 HEK 293 cells). A positive
ontrol (protein extracts from 1,000 HEK 293 cells) was run
n every experiment.
mmunofluorescence analysis of Ki-67 in cardiomyo-
ytes. Coimmunostaining for the proliferation marker
i-67 (Novocastra, Leica Biosystems, Newcastle, United
ingdom) and alpha-sarcomeric actin (clone5c5, Sigma-
ldrich) was performed in 3-m thick myocardial sections
s previously described (29). The percentage of Ki-67
xpression was calculated from the total number of Ki-67
ositive cardiomyocytes and the total number of cardiomy-
cytes per area.
estern blot analysis. Left ventricular tissue was homog-
nized with 500 l lysis buffer (100 mmol/l Tris [pH 6.8],
% sodium dodecyl sulfate [SDS], 20% glycerol) containing
he protease inhibitor M phenylmethanesulfonyl fluoride
.1 mmol/l, leupeptin 0.5 l, and aprotinin 0.5 l. We
eparated 50 g of proteins on SDS–polyacrylamide gel
lectrophoresis 10%. Proteins were transferred to nitrocel-
ulose membrane (162-0112, Bio-Rad Laboratories, Her-
ules, California) blocked with 5% dry milk or blocking
olution for Western blot (Roche) and exposed to rabbit
olyclonal immunoglobin G (IgG) TRF2 (H-300: sc-9143,
anta Cruz Biotechnology, Santa Cruz, California; dilution
:200), mouse monoclonal IgG p16 (F-12: sc-1661, Santa
ruz Biotechnology; dilution 1:250), rabbit polyclonal IgG
nti-p53 (FL-393: sc-6243, Santa Cruz Biotechnology;
ilution 1:500 in dry milk 1%), mouse monoclonal IgG
hk2 (A-11: sc-17747, Santa Cruz Biotechnology; dilution
:1,000 in dry milk 1%), rabbit polyclonal IgG anti-p-Akt
Ser473) (#9271, Cell Signaling Technology, Danvers,
assachusetts; dilution 1:1,500), mouse IgG anti-p-eNOS
pS1177) (#612392, Becton Dickinson; dilution 1:1,000),
nd mouse monoclonal IgG glyceraldehyde-3-phosphate
ehydrogenase (GAPDH) (6C5: sc-32233, Santa Cruz
iotechnology; dilution 1:1,000). For analysis of TERT,
mmunoprecipitation was performed using polyclonal
gG anti-TERT (H-231: sc-7212, Santa Cruz Biotech-
ology) and agarose-A protein goat antirabbit IgG
Sigma-Aldrich). Immunodetection was accomplished
sing goat anti-rabbit IgG (Sigma-Aldrich) and goat
nti-mouse (170-6516, Bio-Rad) secondary antibodies
1:4,000 dilution), and an enhanced chemiluminescence
it (Amersham Biosciences) (30).
everse transcription–polymerase chain reaction. Re-
erse transcription—polymerase chain reaction standardized
o GAPDH was performed using the following primers:
TRF1-for 5=-CATGGACTACACAGACTTAC-3=
TRF1-rev 5=-ATCTGGCCTATCCTTAGACG-3=
5°C, 27 cycles
TRF2-for 5=- TGTCTGTCGCGCATTGAAGA-3=
TRF2-rev 5=-GCTGGAAGACCTCATAGGAA-3=
5°C, 26 cycles
Ku70-for 5=-GAGCATCCAGTGTATCCAGA-3=
Ku70-rev 5=-CAGCATGATCCTCTTGTGAC-3=5°C, 26 cycles
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Ku80-rev 5=-AACTGCAGAGAGATGCCAGA-3=
6°C, 26 cycles
IGF-1-for 5=-CTTCACATCCTCTCTACCT-3=
IGF-1-rev 5=-ATTCTGTAGGTCTTGTTTCC-3=
4°C, 27 cycles
P16-for 5=-ACGGTGCAGATTCGAACTGC-3=
P16-rev 5=-TACACAAAGACCACCCAGCG-3=
3°C, 40 cycles
P53-for 5=-GGGACAGCCAACTCTGTTATG
GC-3=
P53-rev 5=-CTGTCTTCCAGATACTCGGGA
AC-3= 62°C, 30 cycles
Chk2-for 5=-GCTGTCCTCTGAGTAACAAC-3=
Chk2-rev 5=-GAAGTAGAGCTTACAGGTGG-3=
3°C, 40 cycles
GAPDH-for 5=-ACCACAGTCCATGCCATCAC-3=
GADPH-rev 5=-TCCACCACCCTGTTGCTGTA-3=
0°C, 27 cycles
uantification of apoptosis by hairpin oligonucleotide
ssay. To detect apoptosis, 3-m thick paraffin sections of
ormalin-fixed mice heart tissue were examined using the
popTag Peroxidase In Situ Oligo Ligation Kit (Chemicon
nternational, Millipore, Billerica, Massachusetts) (31). The
n situ oligo ligation assay specifically detects apoptosis by
taining only cells that contain double-stranded breaks that
re blunt-ended or have a 1 base 3= overhang (cells contain-
ng nicked, gapped, 3=-recessed, 3=-overhanging ends longer
han 1 base and single-stranded ends are not detected). Unlike
onventional terminal transferase-based labeling (terminal de-
xynucleotidyl transferase mediated 2=-deoxyuridine 5=-
riphosphate nick end labeling [TUNEL]), the assay stains
poptotic but not necrotic or transiently damaged cells (31).
o distinguish between cardiomyocytes and other cardiac
ells, eosin staining was performed after the in situ oligo
igation assay.
tatistical analysis. Band intensities were analyzed by
ensitometry. All values are expressed as mean  standard
rror of the mean. Unpaired Student t tests and analysis of
ariance for multiple comparisons were applied. Post-hoc
omparisons were performed with the Bonferroni adjust-
ent test. The Mann-Whitney U test was used for the
nalysis of the Ki-67 positive cardiomyocytes because the
ata were not normally distributed. SPSS software, version
2.0 (SPSS Inc., Chicago, Illinois), was used. Differences
ere considered significant at p  0.05.
esults
oluntary physical exercise increases telomere-stabilizing
roteins. The mean voluntary running distance was 5,100 
00 m/24 h. Voluntary exercise for 21 days, n  8 to 12 per
roup, did not change heart or body weight or the ratio of
eart weight to tibia length (Fig. 1A). Echocardiography of
ouse hearts showed no change of fractional shortening,nd-diastolic and end-systolic thickness of the interventric- slar septum and the left posterior wall, as well as the left
entricular diameters. Flow-FISH assays showed equal
ean length of telomeres compared with sedentary controls
not shown). At the same time, telomerase repeat amplifi-
ation protocol assays revealed that 3 weeks of exercising
p-regulated cardiac telomerase activity to 230.7  21%,
 0.01 (Fig. 1B). Exercising increased the expression of
ERT in the heart to 165  4%, p  0.05 (Fig. 1C). Next,
he effects of voluntary running on cardiac T-loop stabiliz-
ng proteins were assessed. Three weeks of running had no
ffect on the messenger ribonucleic acid (mRNA) expres-
ion of TRF1, but up-regulated TRF2 mRNA to 145 
2% and TRF2 protein expression to 168.7  8.4%, p 
.05. Exercise up-regulated mRNA expression of the 80-
Da subunit but not the 70-kDa subunit of the repair
rotein Ku (Figs. 1D to 1F).
xercise decreases markers of cellular aging in the
eart. Compared with sedentary controls, the left ventri-
les of the mice that were supplied with a running wheel for
1 days were characterized by a decreased expression of the
ging marker protein p16 (52.6  3.3% of control, p 
.01). Similarly, expression of Chk2, which mediates cell-
ycle arrest and apoptosis, was reduced to 78.7  2.7%, p
.05. The cardiac expression of the proapoptotic transcrip-
ion factor p53 was reduced by one-half (56.4  2.7%, p 
.01). Data are shown in Figure 2. Reverse transcription–
olymerase chain reaction analysis showed that p16 and
hk2 mRNA expression were significantly down-regulated
53.3  7.2% of control, p  0.01 and 75.7  10.8% of
ontrol, p  0.01, respectively), but p53 mRNA levels were
ot altered after running (101  12% of control).
ffects of long-term voluntary exercise on the telomere
omplex and cellular aging. To test if the regulation
bserved after 21 days was a transient effect, mice were
quipped with individual running wheels or no running
heel for the duration of 6 months (n  8 per group). As
xpected, long-term running induced a mild myocardial
ypertrophy that did not impair left ventricular fractional
hortening (Fig. 3A). Compared with the 21-day train-
ng, the long-term training exerted qualitatively and
uantitatively similar effects and significantly increased
he activity of telomerase and the expression TRF2. The
xpression of the markers of reduced cellular life span—
16, Chk2, and p53—was markedly inhibited by 29 
%, 34.8  5%, and 43  4.3%, respectively (p  0.05)
data depicted in Fig. 3). The experiments show that
xercising exerts a continuous and persistent effect on
egulators of cellular survival.
Flow-FISH assays detected no shortening of telomeres in
eukocytes from 6-month-old mice compared with 3-week-
ld mice (Fig. 4A). Consequently, mean telomere length
id not differ between mice running for 6 months (21.6 kb)
nd sedentary animals (21.4 kb). A group of 18-month-old
57/Bl6 animals was studied as a positive control thathowed reduction of telomere length (17.5 kb in 18-month-
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Exercise Regulates Cardiac Telomere Biology August 5, 2008:470–82ld animals compared with 21.8 kb in 3-week-old animals,
 0.001).
Telomere length in the hearts of corresponding left
entricular myocardial sections was directly examined by
ISH using a Cy3-conjugated telomere-specific PNA probe
Figs. 4B and 4C). There was no significant difference in the
yocardial telomere length between mice after 3 weeks and
months of exercise or sedentary condition (3 weeks
edentary: 4,495.0  159.7 individual telomeric fluores-
ence units [TFU]; 6 months sedentary: 5,172.0  361.1
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train-matched wild-type (WT) were subjected to 21
ays of voluntary running. Wild-types exhibited a significant
p-regulation of TRF2 protein expression to 466 121% and
down-regulation of p16, p53, and Chk2 expression to 68 
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er group, p  0.05. However, these exercise-induced
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Figure 2 Exercise Decreases Markers
of Cellular Aging in the Heart
Representative Western blot analysis and quantification of the effects of volun-
tary exercise for 21 days on the left ventricular expression of (A) the senes-
cence marker protein p16, (B) the cell-cycle–checkpoint kinase 2 (Chk2), and
(C) the proapoptotic transcription factor p53. *p  0.05, **p  0.01, n  8
to 12 per group. Abbreviation as in Figure 1.hanges were absent in the TERT/ mice (Fig. 5). cGF-1 and eNOS mediate the effects of exercising on
urvival proteins. Physical exercise is associated with
ncreased serum concentrations of IGF-1 (32). IGF-1 is
ecreased in elderly patients and has been shown to
nhance telomerase delaying cellular aging and death
10). The effect of exercising on cardiac IGF-1 is not
nown. Voluntary running induced up-regulation of
yocardial IGF-1 expression to 169.7  13% (Fig. 6A).
o provide evidence for a potential role of IGF-1 as
ediator of exercise-induced cardiac telomerase activity,
ice were treated with IGF-1 and GH, which increases
ndogenous IGF-1 levels (22). Treatment with GH led
o an 8-fold increase of telomerase activity and IGF-1
p-regulated telomerase activity by 14-fold, p  0.001
Fig. 6B). The IGF-1 treatment of animals resulted in 2-fold
ncreased expression of p-Akt (p  0.01) and p-eNOS (p 
.05) in the myocardium (Figs. 6C to 6E). Running is
nown to up-regulate the expression and function of eNOS,
hich has been confirmed in our model of voluntary
unning at several time points (33–35). To test a potential
ole of eNOS as a mediator of the observed effects, the
xperiments were repeated in eNOS/ mice as a head-to-
ead comparison with strain-matched WT animals (n  8
er group, 21 days). The running distance was not different
etween groups. The results are summarized in Figures 6F
o 6J. Sedentary eNOS/ mice showed a decrease of TRF2
xpression to 70.4 2.4% and an increase of p16 expression
o 130  5.1% compared with WT sedentary mice (p 
.05); telomerase activity and p53 expression were not
ignificantly altered. The eNOS-deficient mice—in contrast
o the WT mice—did not show that exercise modified the
ardiac telomerase, TRF2, p16, p53, or Chk2.
xercise prevents doxorubicin-induced cardiac apoptosis.
oxorubicin is a commonly used antineoplastic drug with
requent cardiotoxicity. The acute doxorubicin-induced cardio-
yopathy is characterized by cellular senescence and apoptosis
21). To test the functional relevance of the observed exercise-
nduced up-regulation of telomere stabilizing and down-
egulation of proapoptotic genes, we exposed C57/Bl6 and
ERT/ mice with and without running wheels to a single
njection with 22.5 mg/kg i.p. of doxorubicin (n  8 per
roup). We measured TRF2 expression 24 h after injection
nd found that it was moderately decreased and telomerase
ctivity was not changed in sedentary control mice
Figs. 7A and 7B). Voluntary running was able to increase
RF2 as well as telomerase activity in the presence of
oxorubicin. Doxorubicin-induced p53 expression in WT
ice by 2-fold to 213  7%, p  0.01. The effect was
ignificantly blunted in mice that had been running volun-
arily for 21 days. Exercise prevented the doxorubicin-
nduced down-regulation of TRF2 and markedly reduced
p-regulation of p53 (163  25% of control, p  0.05 vs.
oxorubicin group) (Figs. 7C and 7D).
Apoptosis was quantitated by hairpin oligonucleotide
ssays. Interestingly, 21 days of voluntary exercising de-
reased apoptotic cardiomyocytes by 5-fold (0.03  0.01 vs.
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reased cardiomyocyte apoptosis in the inactive animals
0.29  0.08%, p  0.05). However, mice supplied
ith running wheels were completely protected from
oxorubicin-induced programmed cell death of cardiomyo-
ytes (Fig. 7D). Cardiomyocyte apoptosis rate of sedentary
ersus running TERT/ B6.129S mice was in the same
ange of the corresponding C57/Bl6 strain as discussed
reviously (0.51  0.21% and 0.21  0.03%, p  0.03 for
ontrol vs. control  doxorubicin). In contrast, sedentary
ERT/ mice of the same strain showed an increased
usceptibility to doxorubicin-induced apoptosis (0.73 
.14%, p  0.05 vs. WT doxorubicin control) (Fig. 7F). In
hese mice, exercise was not able to render a significant
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Figure 3 Effects of Long-Term Voluntary Exercise on the Telom
Effects of long-term voluntary exercise (6 months) on (A) the ratio of heart weight
(C) expression of TRF2, (D) p16, (E) Chk2, and (F) p53. *p  0.05, **p  0.01rotection (p  NS for TERT/ doxorubicin control vs. vunner; p 0.001 vs. WT doxorubicin runner) demonstrat-
ng the importance of TERT for the exercise-mediated
ffects on apoptosis.
iscussion
he study identifies a novel effect of physical exercise on the
eart. Compared with mice kept under the regular condi-
ions of laboratory animals, voluntary running exercise
p-regulated telomere-stabilizing proteins, reduced cellular
enescence, and prevented doxorubicin-induced apoptotic
ell death. Further characterization shows that the effect
epends on TERT expression and is mediated by IGF-1
nd eNOS. The effect was observed after 3 weeks of
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ion and longevity (1–3,5,6,8,9,36). However, the underly-
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Figure 4 Telomere Length in Sedentary and Running Mice
(A) Telomere length of blood leukocytes in 3-week (wk)-, 6-month (mo)-, and
18-month-old sedentary mice and in mice with running wheels exercising for 6
months (run) determined by Flow-fluorescence in-situ hybridization (FISH)
assays displayed in base pairs (bp) and expressed as box plots, indicating the
median as horizontal lines and boxes as 25th and 75th percentiles as well as
whiskers as 10th and 90th percentiles. ***p  0.001 versus 3 wk and 6 mo,
n  8 to 12 per group. (B) Effects of 6 months of running wheel exercise com-
pared with 3-week-, 6-month, and 18-month-old sedentary condition on murine
cardiomyocyte telomere length as determined by quantitative (Q) FISH. Results
are presented in mean telomere fluorescence units per high-power field as box
plots. ***p  0.001 versus every other condition (n  4 per condition, with
each n consisting of 2 myocardial sections and 3 high-power fields captured
from each section). (C) Exemplary images of murine cardiomyocyte telomeres
(QFISH, red dots) and the corresponding nuclei (4,=6-Diamidino-2-phenylin-
doldihydrochloride [DAPI], blue) for 3-week- and 18-month-old sedentary condi-
tion, 40 magnification. (D) Quantification (n  8) and representative
fluorescence microscopic image of Ki-67–positive nuclei (red) in cardiomyocytes
identified by alpha-sarcomeric actin coimmunostaining (green) after 3 weeks of
voluntary running. Nuclei are stained blue by DAPI. 100 magnification. *p 
0.05. LV  left ventricle.ng molecular mechanisms remain only partially understood7). Here we observe that exercising increases the activity of
he telomerase, the reverse transcriptase responsible for the
xtension of telomeric repeat sequences, as well as the
xpression of its catalytic subunit, TERT. Both telomerase
nd TERT have been shown to regulate cardiac muscle cell
rowth and survival (10,11,16,37), and telomerase ribonu-
leic acid knockout mice (Terc/) develop cardiac dysfunc-
ion, increased expression of p53, and increased apoptosis (16).
verexpression of TERT causes hypertrophy in cultured
ardiac myocytes and protects from apoptosis in vitro and
n vivo (11). In addition to the effects on telomerase and
ERT, exercising mice showed up-regulation of TRF2
RNA and protein expression. Telomere repeat binding
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Figure 5 No Effect of Voluntary Exercise in TERT/ Mice
Representative Western blot analysis and quantification of the effects of volun-
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Figure 6 IGF-1 and eNOS Mediate the Effects of Exercising on Survival Proteins
(A) Effects of 21 days voluntary running on cardiac expression of insulin-like growth factor (IGF) mRNA (n  8). (B) Regulation of telomerase activity by treatment with
growth hormone (GH) (2.5 g/g once per day for 7 days) and mouse IGF-1 (1.5 g/g 3 times per day for 2 days) (n  4). (C) Representative Western blots and (D)
quantification of phosphorylated Akt (pAkt) and (E) phosphorylated endothelial nitric oxide synthase (peNOS) (n  4 per group). Effects of 21 days of running in B6.129S
WT and eNOS-deficient (eNOS/) mice compared with sedentary controls on (F) cardiac telomerase activity, (G) expression of TRF2, (H) p16, (I) Chk2, and (J) p53
(n  8 per group). Standardization for GAPDH. *p  0.05, **p  0.01, ***p  0.001. Abbreviations as in Figures 1, 2, and 5.
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ontributes to the formation of the chromosome-protecting
-loops (12). Importantly, TRF2 serves as the binding
latform for additional telomere-associated proteins and
ediates signaling to DNA damage checkpoint controls
13,14). Interestingly, cardiac apoptosis in human heart
ailure was associated specifically with defective expression
f TRF2 and activation of the DNA damage checkpoint
inase, Chk2 (17). In addition, exogenous TRF2 was shown
o confer protection from oxidative stress (17). In circulating
rogenitor cells, TRF2 was identified as a regulator of
lonogenic potential and migratory capacity that can be
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0.05 versus Doxo-treated sedentary control. Abbreviations as in Figures 1 and 5.odified by pharmacological treatment (38,39). Here, vol- Sntary exercise resulted in up-regulation of telomerase,
ERT, and TRF2 after only 3 weeks and the regulation
ersisted for at least 6 months. Therefore, physical exercise
epresents a potent regulator of the telomere complex.
Relatively little is known about the physiologic develop-
ent of telomere length in healthy untreated WT C57/Bl6
ice over time (8,14,40). After 6 months, we observed no
hortening of telomere length, and telomere length did not
iffer between running and sedentary animals both in blood
eucocytes as well as in the myocardium. A control group of
8-month-old C57/Bl6 mice exhibited significantly shorter
elomeres. This finding may be interpreted in several ways.
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otentially observe a protective effect of exercising on
elomere length. On the other hand, it is possible that the
nhanced telomerase activity may counteract a putative
elomerase-independent negative effect of exercising. How-
ver, the interesting aspect of these data is that the regula-
ion of the telomere-regulating proteins by exercise-
ediated survival signaling seems to be independent of
elomere length. Indeed, recent evidence suggests a direct
elomerase-dependent transcriptional regulation of genes
nvolved in cell growth, which has been recently suggested
s an additional mechanism by which telomerase promotes
ell proliferation. The regulation of telomerase activity and
ubsequent replicative potential is reported to occur rapidly
nd independently of telomere length in several cell types
8,22,41). Defects in mice lacking the ribonucleic acid
omponent of telomerase involve apoptosis, not just prolif-
ration defects, and telomerase directly protects cells against
rogrammed cell death (8,16,42,43). Similarly, TRF2 was
uggested to mediate proapoptotic signaling in post-mitotic,
oncycling cardiomyocytes (17) and was shown to signal
ndependently of telomere length in endothelial progenitor
ells (39). It therefore seems likely that the telomeric
omplex serves as a regulator of cellular aging and function
eyond and potentially independently of protecting telo-
ere length.
Several gene products implicated in senescence and cell
eath, such as transformation-related protein p53, p16, and
hk2, have been identified downstream of the telomeric
omplex (10,13,14,16–19). The tumor suppressor protein
53 has been shown to mediate telomere dysfunction
16,19). Protein p53 modulates apoptosis and senescence by
ncreasing the expression of specific proteins, including Bax,
ad, and p21. Importantly, p53 was recently identified as a
ey mediator of maladaptive cardiac remodeling essential
or the transition from cardiac hypertrophy to heart failure
18). Here, the data identify voluntary running as a novel
nd potent inhibitor of cardiac Chk2, p16, and p53.
To test whether the exercise-induced regulation of the
elomere complex and the regulation of p53 represent a
oincidence or may be causally related, the experiments were
epeated in TERT-deficient mice. Running induced very
imilar regulation of the transformation-related proteins in
ERT/ WT and C57/Bl6 mice, but the exercise-
ediated effects were absent in the TERT/ mice. These
ata support the concept that the regulation of the telomeric
omplex by exercising mediates the downstream effects on
poptosis.
Physical exercise is associated with increased serum con-
entrations of IGF-1 (32,44). IGF-1 enhances telomerase,
elaying cellular aging and death (10,22). Cardiac overex-
ression of IGF-1 in transgenic mice increases the heart
eight (45,46). In IGF-1 transgenic mice, cardiac stem cell
ivision is increased, which is accompanied by enhanced
elomerase activity and delayed senescence (10). Similarly,
ge-dependent impairment of endothelial progenitor cells is torrected by GH-mediated increase of IGF-1 (22). IGF-1
nd its ligand may have the potential to regulate the re-entry
f adult ventricular myocytes into the cell cycle (46,47). In
ontrast to the systemic effects of exercising on IGF-1, the
ffect of exercise on local cardiac IGF-1 is not known. Here,
he data show that voluntary running increases the expres-
ion of IGF-1 in the heart. To test the role of IGF-1 in
xercise-induced telomerase regulation, mice were treated
ith recombinant GH and IGF-1, which resulted, respec-
ively, in powerful 8- and 14-fold increases of telomerase
ctivity. The effects of IGF-1 on telomerase have been
hown to be associated with the regulation of endothelial
itric oxide and phosphatidylinositol 3-kinase–Akt-p70S6K
ignaling, a pathway that plays an important role in regu-
ating cardiac hypertrophy, viability, and homeostasis
22,48). In line with these data, treatment with recombinant
GF-1 led to significant increases in myocardial expression
f p-Akt and p-eNOS. Indeed, one of the best characterized
olecular effects of exercising in the model of voluntary
unning is the up-regulation of eNOS (33,35). Therefore,
he experiments were repeated in eNOS/mice showing
hat the effects of exercising on telomere-regulating proteins
nd subsequent survival signaling are mediated via eNOS.
aken together, the data identify IGF-1, Akt, and eNOS as
mportant mediators of the exercise-induced up-regulation
f telomerase activity.
Apoptosis has been implicated in both acute and chronic
eart diseases causing progressive loss of cardiac myocytes.
nd-stage human heart failure is characterized by increased
yocyte apoptosis (20). Similarly, several forms of acute
oxic cardiomyopathy are characterized by cellular senes-
ence and apoptosis; however, our understanding of poten-
ial strategies to prevent cardiomyocyte senescence and
poptosis is limited (20). Doxorubicin is a potent, widely
sed antineoplastic agent in cancer chemotherapy. However,
ts clinical application is compromised by its dose-dependent
ardiotoxicity mediated by cardiomyocyte apoptosis (21).
ere, we applied the well-characterized model of acute
oxorubicin-induced cardiac apoptosis to test if the ob-
erved effects of exercising on telomere-regulating proteins
nd survival markers are able to confer protection from
ardiomyocytes apoptosis. After acute exposure to doxoru-
icin, mice showed a small reduction of TRF2 expression.
owever, in mice that had access to a running wheel during
he 3 weeks prior to doxorubicin exposure, TRF2 was
ignificantly up-regulated. Similarly, the doxorubicin-
nduced increase of cardiac p53, a key mediator of cardiac
ell death (16,18,19), was markedly blunted in mice of the
unning group. Cardiomyocyte apoptosis was assessed by
he hairpin oligonucleotide assay that specifically detects
poptosis by selectively staining cells that contain double-
tranded DNA breaks that are blunt-ended or have a 1 base
= overhang whereas cells containing nicked, gapped, 3=-
ecessed, 3=-overhanging ends longer than 1 base, and
ingle-stranded ends are not detected. Unlike conventional
erminal transferase-based labeling, the assay stains apopto-
t
h
m
t
i
m
b
e
d
a
i
m
s
v
t
r
d
t
s
p
m
a
t
o
m
q
c
p
m
s
T
h
t
e
l
I
o
s
c
w
d
I
t
t
t
c
s
s
s
d
h
m
d
I
r
i
p
s
i
c
t
t
t
A
T
J
R
f
I
H
R
1
1
1
1
1
1
1
481JACC Vol. 52, No. 6, 2008 Werner et al.
August 5, 2008:470–82 Exercise Regulates Cardiac Telomere Biologyic but not necrotic or transiently damaged cells (31). The
airpin oligonucleotide experiments revealed that providing
ice with a running wheel to allow voluntary running for
he relatively short period of 3 weeks represents a powerful
ntervention to protect from doxorubicin-induced cardio-
yocyte apoptosis.
Somewhat unexpectedly, voluntary running decreased the
asal rate of cardiomyocyte apoptosis compared with sed-
ntary animals. Ascensão et al. (49) observed prevention of
oxorubicin-induced increase in Bax, Bax-to-Bcl-2 ratio,
nd tissue caspase-3 activity by a 14-week training protocol
n rats but no effect of exercise on the basal rate of these
arkers in left ventricular homogenates. Chicco et al. (50)
how a decrease of caspase-3 activity in the rats’ left
entricles induced by exercising both in the presence and in
he absence of doxorubicin; however, the latter effect did not
each statistical significance. None of these studies has
irectly assessed cardiomyocyte specific apoptosis; in addi-
ion, there were significant differences in the protocols,
pecies, and modalities of training. In agreement with
revious studies, long-term voluntary running (e.g., 6
onths) is associated with increased heart weight, an
daptive change without impairment of cardiac function. In
he light of these data, it is interesting to speculate that the
pportunity to exercise resembles the natural habitat of mice
ore closely than cages without running wheels. Conse-
uently, the inactivity of regular laboratory mice could be
onsidered the experimental intervention in this study. The
rovocative hypothesis would be that the observed cardiac
orphology in voluntary exercise is “normal” and that
edentary animals exhibit an adaptive cardiac hypotrophy.
he notion of an “anti-aging” effect of exercising on the
eart is supported by earlier reports in the literature (51)
hat survival rates decrease in sedentary as opposed to
xercising rodents.
The effects of physical activity and inactivity are not
imited to the regulation of telomere-regulating proteins.
mproved cardiac antioxidant capacity and beneficial effects
n both circulating progenitor cells and cardiac resident
tem cells are likely to contribute to the molecular and
ellular actions of exercise (7,10,22,35,52). In agreement
ith this hypothesis, Ki-67–positive cardiomyocytes were
etected in the hearts of running but not in sedentary mice.
n our opinion, future research is needed to further charac-
erize both the quantitative and the cell-type specific con-
ribution of the exercise-induced mechanisms with the aim
o develop more specific therapeutic interventions. Specifi-
ally, the effects of exercise on telomere biology in cardiac
tem cells may be of functional significance (10).
A significant proportion of elderly heart failure patients
how no other confounding variables suggesting that age as
uch may be a primary cause of cardiac decompensation and
iastolic dysfunction (53,54). Shortening of the telomeres
as recently been shown to predict cardiac morbidity and
ortality, and telomere length of circulating leukocytes isecreased in patients with chronic heart failure (9,14,17,55).n addition, recent evidence suggests that telomere biology
epresents an indicator for the effect of a pharmacologic
ntervention (56). Here, we identify physical exercise as a
otent antisenescent intervention to up-regulate telomere-
tabilizing proteins and to reduce cardiomyocyte apoptosis,
mproving the molecular understanding of the beneficial
ardiovascular effects of exercise. Furthermore, the data set
he stage to prospectively investigate these novel cardiopro-
ective effects in specific clinical situations, for example, for
he prevention of doxorubicin-induced cardiomyopathy.
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